1332721-16-0

Basic information

• Product Name: 2-(1,3-difluoropropan-2-yloxy)-4-fluoroaniline
• Synonyms: 2-(1,3-difluoropropan-2-yloxy)-4-fluoroaniline
• CAS NO: 1332721-16-0
• Molecular Weight: 205.18
• Mol File: 1332721-16-0.mol

Chemical Properties

• CAS DataBase Reference: 2-(1,3-difluoropropan-2-yloxy)-4-fluoroaniline(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(1,3-difluoropropan-2-yloxy)-4-fluoroaniline(1332721-16-0)
• EPA Substance Registry System: 2-(1,3-difluoropropan-2-yloxy)-4-fluoroaniline(1332721-16-0)

Safety Data

• Hazardous Substances Data: 1332721-16-0(Hazardous Substances Data)

Upstream product

• 1332721-15-9 2-(1,3-Difluoropropan-2-yloxy)-4-fluoro-1-nitrobenzene 
• 446-35-5 2,4-Difluoronitrobenzene 

Relevant articles and documents

HALOGEN OR CYANO SUBSTITUTED THIENO [2,3-D]PYRIMIDINES HAVING MNK1/MNK2 INHIBITING ACTIVITY FOR PHARMACEUTICAL COMPOSITIONS

The present invention relates to novel thienopyhmidine compounds of general formula (I), pharmaceutical compositions comprising these compounds and their therapeutic use for the prophylaxis and/or treatment of diseases which can be influenced by the inhib

THIENOPYRIMIDINES CONTAINING A SUBSTITUTED ALKYL GROUP FOR PHARMACEUTICAL COMPOSITIONS

The present invention relates to novel thienopyhmidine compounds of general formula pharmaceutical compositions comprising these compounds and their therapeutic use for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof.

THIENOPYRIMIDINES CONTAINING A SUBSTITUTED ALKYL GROUP FOR PHARMACEUTICAL COMPOSITIONS

The present invention relates to novel thienopyrimidine compounds of general formula pharmaceutical compositions comprising these compounds and their therapeutic use for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof.